Tarsus Pharmaceuticals, Inc.
Total Trades
117
Buys
3
Sells
98
Largest Trade
N/A
Insiders
13
Institutional Funds
193
Inst. Value
$1M+
Activist Filings
39
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Greenstein Leonard M. | CFO | SELL | $1K–$15K | 1K | $12.55 | Mar 24, 2023 |
| Trevejo Jose M. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $12.58 | Mar 24, 2023 |
| Neervannan Seshadri | COO | SELL | $1K–$15K | 1K | $12.55 | Mar 23, 2023 |
| Wahl Bryan | General Counsel | SELL | $1K–$15K | 1K | $12.55 | Mar 23, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $15K–$50K | 2K | $12.55 | Mar 23, 2023 |
| Whitfield Dianne C. | CHRO | SELL | $1K–$15K | 1K | $12.55 | Mar 23, 2023 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $1K–$15K | 1K | $12.55 | Mar 23, 2023 |
| Whitfield Dianne C. | CHRO | SELL | $1K–$15K | 649 | $12.94 | Mar 21, 2023 |
| Wahl Bryan | General Counsel | SELL | $1K–$15K | 696 | $12.94 | Mar 21, 2023 |
| Neervannan Seshadri | COO | SELL | $1K–$15K | 740 | $12.94 | Mar 21, 2023 |
| Trevejo Jose M. | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 1K | $12.94 | Mar 21, 2023 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $1K–$15K | 697 | $12.94 | Mar 21, 2023 |
| Holdbrook Mark J. | V.P. | SELL | $1K–$15K | 386 | $12.94 | Mar 21, 2023 |
| Greenstein Leonard M. | CFO | SELL | $1K–$15K | 649 | $12.94 | Mar 21, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $15K–$50K | 2K | $12.96 | Mar 21, 2023 |
| Holdbrook Mark J. | V.P. | EXERCISE | N/A | 3K | — | Mar 17, 2023 |
| Holdbrook Mark J. | V.P. | SELL | $1K–$15K | 187 | $13.43 | Mar 17, 2023 |
| Wahl Bryan | General Counsel | EXERCISE | N/A | 5K | — | Mar 17, 2023 |
| Wahl Bryan | General Counsel | SELL | $1K–$15K | 337 | $13.43 | Mar 17, 2023 |
| Whitfield Dianne C. | CHRO | SELL | $1K–$15K | 313 | $13.43 | Mar 17, 2023 |
| Whitfield Dianne C. | CHRO | EXERCISE | N/A | 4K | — | Mar 17, 2023 |
| Trevejo Jose M. | Chief Medical Offi… | SELL | $1K–$15K | 499 | $13.43 | Mar 17, 2023 |
| Trevejo Jose M. | Chief Medical Offi… | EXERCISE | N/A | 8K | — | Mar 17, 2023 |
| Mottiwala Aziz | Chief Commercial O… | SELL | $1K–$15K | 336 | $13.43 | Mar 17, 2023 |
| Mottiwala Aziz | Chief Commercial O… | EXERCISE | N/A | 5K | — | Mar 17, 2023 |
| Neervannan Seshadri | COO | EXERCISE | N/A | 5K | — | Mar 17, 2023 |
| Neervannan Seshadri | COO | SELL | $1K–$15K | 357 | $13.43 | Mar 17, 2023 |
| Greenstein Leonard M. | CFO | SELL | $50K–$100K | 5K | $13.44 | Mar 17, 2023 |
| Greenstein Leonard M. | CFO | EXERCISE | N/A | 4K | — | Mar 17, 2023 |
| Azamian Bobak R. | President/CEO and … | EXERCISE | N/A | 11K | — | Mar 17, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 9K | $13.76 | Mar 17, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $50K–$100K | 6K | $15.02 | Mar 10, 2023 |
| Greenstein Leonard M. | CFO | SELL | $50K–$100K | 5K | $15.12 | Feb 17, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $15.28 | Feb 17, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 9K | $15.14 | Feb 10, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $50K–$100K | 5K | $15.45 | Jan 25, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $1K–$15K | 411 | $15.00 | Jan 24, 2023 |
| Greenstein Leonard M. | CFO | SELL | $50K–$100K | 5K | $14.56 | Jan 20, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $14.57 | Jan 20, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $50K–$100K | 4K | $15.11 | Jan 13, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $15K–$50K | 2K | $15.16 | Jan 12, 2023 |
| Azamian Bobak R. | President/CEO and … | SELL | $100K–$500K | 8K | $14.57 | Dec 22, 2022 |
| Azamian Bobak R. | President/CEO and … | SELL | $1K–$15K | 535 | $15.01 | Dec 20, 2022 |
| Greenstein Leonard M. | CFO | SELL | $50K–$100K | 5K | $14.64 | Dec 16, 2022 |
| Azamian Bobak R. | President/CEO and … | SELL | $50K–$100K | 6K | $15.08 | Dec 16, 2022 |
| Whitfield Dianne C. | CHRO | SELL | $15K–$50K | 1K | $16.90 | Dec 6, 2022 |
| Wahl Bryan | General Counsel | SELL | $15K–$50K | 1K | $16.90 | Dec 6, 2022 |
| Whitfield Dianne C. | CHRO | EXERCISE | N/A | 10K | — | Dec 2, 2022 |
| Whitfield Dianne C. | CHRO | SELL | $15K–$50K | 2K | $16.62 | Dec 2, 2022 |
| Wahl Bryan | General Counsel | EXERCISE | N/A | 10K | — | Dec 2, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 193 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Deep Track Capital, LP | 3.0M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 1.9M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 1.2M | $1M+ | SH |
| Assenagon Asset Management S.A. | 1.1M | $1M+ | SH |
| STATE STREET CORP | 929K | $1M+ | SH |
| LORD, ABBETT & CO. LLC | 836K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 822K | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 729K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 585K | $1M+ | SH |
| TORONTO DOMINION BANK | 510K | $1M+ | SH |
| Clearbridge Investments, LLC | 506K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 474K | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 361K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 356K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 333K | $1M+ | SH |
| TimesSquare Capital Management, LLC | 332K | $1M+ | SH |
| MPM BioImpact LLC | 329K | $1M+ | SH |
| Cormorant Asset Management, LP | 250K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 173K | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 162K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
2.8%
1.2M shares
SC 13G/A · Nov 14, 2025
7.1%
3.0M shares
SC 13G/A · Aug 14, 2025
8.1%
3.4M shares
SC 13G · Jul 28, 2025
5.6%
2.4M shares
SC 13G/A · May 15, 2025
5.9%
2.5M shares
SC 13G/A · May 7, 2025
4.7%
1.9M shares
SC 13G/A · Apr 24, 2025
7.4%
3.1M shares
SC 13G/A · Feb 13, 2025
4.9%
1.9M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2024
6.4%
2.4M shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2024
1.3%
500K shares
SC 13G/A · Nov 12, 2024
5.5%
2.1M shares
Jennison Associates LLC IRS Identification #52-2069785 (formerly 13-2631108)
SC 13G · Nov 12, 2024
5.7%
2.2M shares
SC 13G/A · Nov 8, 2024
9.9%
3.8M shares
Frazier Life Sciences IX, L.P . 2.
SC 13G/A · Nov 6, 2024
4.2%
1.6M shares
SC 13G/A · Nov 4, 2024
5.5%
2.1M shares
SC 13G/A · Oct 21, 2024
9.9%
3.8M shares
SC 13G/A · Feb 14, 2024
6.7%
2.2M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
4.8%
1.6M shares
SC 13G/A · Feb 14, 2024
9.5%
3.2M shares
SC 13G/A · Feb 13, 2024
2.7%
895K shares
Cowen Financial Products LLC 27-0423711
SC 13G/A · Feb 2, 2024
5.8%
1.9M shares
SC 13G · Jan 26, 2024
7.6%
2.5M shares
Paradigm BioCapital Advisors LP
SC 13G · Jan 22, 2024
5.8%
1.9M shares
Cowen Financial Products LLC 27-0423711
SC 13G · May 5, 2023
5.2%
1.4M shares
SC 13G/A · Feb 14, 2023
7.5%
2.0M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2023
4.2%
1.1M shares
SC 13G/A · Feb 14, 2023
4.9%
1.3M shares
SC 13G/A · Feb 14, 2023
9.6%
2.5M shares
SC 13G/A · Feb 13, 2023
8.5%
2.3M shares
SC 13G/A · Feb 10, 2023
5.0%
1.3M shares
SC 13G · May 13, 2022
7.9%
2.1M shares
SC 13G · May 11, 2022
5.0%
1.3M shares
SC 13G/A · Feb 14, 2022
6.3%
1.3M shares
SC 13G/A · Feb 14, 2022
6.8%
1.4M shares
SC 13G/A · Feb 14, 2022
6.1%
1.3M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
3.7%
765K shares
SC 13G/A · Feb 14, 2022
9.7%
2.0M shares
SC 13G/A · Feb 11, 2022
14.4%
3.0M shares
Frazier Life Sciences IX, L.P.
SC 13G/A · Jan 28, 2022
6.9%
1.4M shares